II
INO icon

Inspire Investing’s Inovio Pharmaceuticals INO Stock Holding History

Inspire Investing’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed -$1K – 605
2020
Q1 		$1K Buy
+10
New +$617 ﹤0.01% 734
2018
Q1 		– Sell
-16
Closed -$1K – 436
2017
Q4 		$1K Buy
+16
New +$992 ﹤0.01% 868

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Inspire Investing's INO Position: Q2 2020 in Review

Inspire Investing sold out of Inovio Pharmaceuticals (INO) in Q2 2020, closing a stake of 10 shares — an estimated $1K sold.

Inspire Investing first reported a position in INO in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 214 funds tracked by Wall St. Rank hold INO as of Q2 2020.

  • Inspire Investing reported no remaining Inovio Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Inspire Investing sold 10 Inovio Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Inspire Investing first reported a position in Inovio Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Inspire Investing's Inovio Pharmaceuticals position peaked at $1K in Q1 2020.
  • 214 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.